Overview
Pinealon is a cognitive-focused compound. Synthetic tripeptide (Glu-Asp-Arg).
With a half-life of ~24 minutes, Pinealon requires daily administration in most observed protocols. Administered via nasal, SubQ, and oral injection, it has a bioavailability of approximately 60% via its primary route.
Half-life approximately 15–30 minutes. Low molecular weight enables rapid absorption across multiple administration routes including nasal. One-compartment model.
Mechanism of Action
Pinealon's pharmacological activity involves the following key pathways:
Neurotrophin Modulation
Pinealon interacts with central nervous system pathways involved in neuroplasticity and cognitive function.
CNS Penetration
Pinealon reaches the central nervous system via intranasal administration, bypassing the blood-brain barrier.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
5 mg/day
Route
Intranasal
Frequency
2-3 times daily
Duration
4-12 weeks
Dose
20 mg/day
Route
Intranasal
Frequency
2-3 times daily
Duration
4-12 weeks
Reconstitution Steps
Pinealon is supplied as a lyophilized (freeze-dried) powder and requires reconstitution before use. Common vial sizes: 10 mg, 20 mg.
-
1
Gather Supplies
You will need your Pinealon lyophilized vial (most commonly 20 mg), bacteriostatic water for injection, an insulin syringe (100-unit), and alcohol swabs. Pinealon doses are in the microgram range, so accurate reconstitution volume is important.
-
2
Swab and Prepare
Wipe the rubber septum of both the Pinealon vial and the bacteriostatic water vial with a fresh alcohol swab. Allow both to air-dry for 10–15 seconds before proceeding.
-
3
Draw Bacteriostatic Water
For a 20 mg vial, draw 3 mL of bacteriostatic water, yielding a concentration of approximately 6.67 mg/mL (6,670 mcg/mL). This concentration allows practical measurement of doses in the 100–500 mcg range using a standard insulin syringe.
-
4
Add Water to Vial
Insert the needle and angle it so water runs gently down the inner glass wall of the vial onto the peptide powder. Avoid forceful injection directly onto the powder to prevent foaming and peptide degradation.
-
5
Swirl Gently to Dissolve
Roll the vial between your palms until the powder is fully dissolved. Pinealon is a small, highly water-soluble tripeptide and should dissolve quickly into a clear solution.
-
6
Label and Store
Label with the reconstitution date and concentration. Refrigerate at 2–8°C and use within 4 weeks. For intranasal use, draw the desired volume into a nasal atomiser device at time of each dose.
Quick Reconstitution Math
20 mg vial + 3 mL bac water = 6,670 mcg/mL. For a 200 mcg dose, draw approximately 3 units on a 100-unit insulin syringe. For a 500 mcg dose, draw approximately 7.5 units. Use the Milligram reconstitution calculator for custom vial sizes.
Lyophilized vials stable refrigerated at 2–8°C or frozen at −20°C for long-term storage. Reconstituted solution stable at 2–8°C for up to 4 weeks. Avoid repeated freeze-thaw cycles on reconstituted solution.
Frequently Asked Questions
What is Pinealon and how does it work?
Pinealon (also known by its sequence abbreviation EDR) is a synthetic tripeptide composed of glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg). It belongs to the class of Khavinson peptide bioregulators, developed by Russian gerontologist Vladimir Khavinson. Unlike most peptides that act through surface receptors, Pinealon is understood to interact with cellular DNA and influence gene expression patterns in central nervous system cells, supporting neuronal survival, mitochondrial function, and resistance to oxidative stress.
What is the half-life of Pinealon and how quickly does it clear the body?
Pinealon is an ultra-short tripeptide with a correspondingly brief plasma half-life – estimated at approximately 15 minutes. Despite this rapid clearance, its effects on gene expression are understood to persist beyond the presence of the peptide itself, consistent with the epigenetic regulatory model proposed for Khavinson bioregulators. Daily dosing is the standard approach in community protocols, with some practitioners using short intensive cycles of 10–20 days rather than extended continuous use.
How long does Pinealon take to show effects?
Because Pinealon acts at the level of gene expression rather than through immediate receptor agonism, timelines are generally slower than peptides with direct receptor activity. Community reports and Eastern European clinical observations most commonly describe gradual improvements in cognitive clarity, sleep quality, and mental resilience appearing over 2–4 weeks of consistent use. The compound is typically positioned for long-term neuroprotective benefits rather than acute cognitive enhancement.
What are the commonly reported effects of Pinealon?
The most frequently reported observations include improved sleep quality and depth, enhanced mental clarity, reduced brain fog, and a general sense of neurological stability. Some community reports note improved mood and emotional regulation over extended use. In research models, Pinealon has demonstrated increases in cell viability under oxidative stress conditions, suppression of free radical accumulation, and activation of neuronal proliferative processes. All human-use data remains observational and primarily derives from Eastern European clinical practice.
How is Pinealon administered – nasal or subcutaneous?
Pinealon is administered via subcutaneous injection or intranasal delivery. Subcutaneous injection is the standard method in clinical protocols and is considered to provide reliable systemic absorption. Intranasal administration is also commonly used in community protocols – the small tripeptide structure is considered to support efficient mucosal and potential direct nose-to-brain transport. Typical doses are 100–300 mcg per day subcutaneously, with higher doses used intranasally to account for variable mucosal absorption.
How should Pinealon be cycled and what is the typical protocol duration?
Khavinson bioregulator protocols, including Pinealon, are characteristically used in short concentrated cycles rather than continuous daily use. The most commonly observed approach is 10–20 day intensive cycles, repeated 2–3 times per year with 3–6 month intervals between cycles. Some practitioners also use 8–12 week extended cycles at lower daily doses. The intermittent cycling model is consistent with the epigenetic regulatory mechanism – effects on gene expression are considered to persist beyond the dosing period.